5-Fluorouracil Combo Promising

September 1, 2003
Lawrence M. Prescott, Ph.D.

Lawrence Prescott is a medical writer based in San Diego, California.

Chicago - The combination of oxaliplatin (Eloxatin) and a continuous infusion of 5-fluorouracil (5-FU) appears to offer a promising chemotherapeutic alternative to the presently administered cisplatin or carboplatin-based approach for the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck, Marc Debled, M.D., said at the American Society of Clinical Oncology meeting.